Myostellar Pty Ltd

Myostellar is developing novel therapies for the treatment of muscular dystrophies which can stimulate skeletal muscle regeneration with minimal fibrosis. There are currently no therapeutics that do so, and Myostellar’s research is showing great promise for sufferers of muscular dystrophy and acute muscle injury which could lead to life-changing improvements in the lives of countless patients.

Lead researchers: Peter Currie & Mikaël Martino 
Contact: bo.yun@myostellar.com